|
Name |
Asperterpene I
|
Molecular Formula | C27H40O9 | |
IUPAC Name* |
methyl (1R,2S,4aS,4bS,7R,8aS,10S,10aS)-7,10-dihydroxy-2-[(2S)-2-hydroxy-3-methoxy-2-methyl-3-oxopropanoyl]-2,4b,8,8,10a-pentamethyl-3-methylidene-9-oxo-1,4,4a,5,6,7,8a,10-octahydrophenanthrene-1-carboxylate
|
|
SMILES |
C[C@@]12CC[C@H](C([C@H]1C(=O)[C@H]([C@]3([C@H]2CC(=C)[C@@]([C@@H]3C(=O)OC)(C)C(=O)[C@@](C)(C(=O)OC)O)C)O)(C)C)O
|
|
InChI |
InChI=1S/C27H40O9/c1-13-12-14-24(4)11-10-15(28)23(2,3)17(24)16(29)19(30)26(14,6)18(20(31)35-8)25(13,5)21(32)27(7,34)22(33)36-9/h14-15,17-19,28,30,34H,1,10-12H2,2-9H3/t14-,15+,17+,18-,19+,24-,25+,26-,27-/m0/s1
|
|
InChIKey |
IIUYCUAFSQXIAZ-XNCNABBASA-N
|
|
Synonyms |
CHEMBL4218151; Asperterpene I; BDBM50459482
|
|
CAS | NA | |
PubChem CID | 139590116 | |
ChEMBL ID | CHEMBL4218151 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 508.6 | ALogp: | 1.8 |
HBD: | 3 | HBA: | 9 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 147.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 36 | QED Weighted: | 0.295 |
Caco-2 Permeability: | -5.675 | MDCK Permeability: | 0.00013126 |
Pgp-inhibitor: | 0.832 | Pgp-substrate: | 0.991 |
Human Intestinal Absorption (HIA): | 0.042 | 20% Bioavailability (F20%): | 0.022 |
30% Bioavailability (F30%): | 0.39 |
Blood-Brain-Barrier Penetration (BBB): | 0.206 | Plasma Protein Binding (PPB): | 39.37% |
Volume Distribution (VD): | 0.599 | Fu: | 64.92% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.962 |
CYP2C19-inhibitor: | 0.013 | CYP2C19-substrate: | 0.764 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.036 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.029 |
CYP3A4-inhibitor: | 0.872 | CYP3A4-substrate: | 0.831 |
Clearance (CL): | 3.66 | Half-life (T1/2): | 0.072 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.402 |
Drug-inuced Liver Injury (DILI): | 0.425 | AMES Toxicity: | 0.058 |
Rat Oral Acute Toxicity: | 0.537 | Maximum Recommended Daily Dose: | 0.548 |
Skin Sensitization: | 0.074 | Carcinogencity: | 0.524 |
Eye Corrosion: | 0.788 | Eye Irritation: | 0.127 |
Respiratory Toxicity: | 0.987 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003850 | 0.573 | D0H2MO | 0.299 | ||||
ENC006004 | 0.552 | D0F7NQ | 0.260 | ||||
ENC003564 | 0.364 | D0X7XG | 0.257 | ||||
ENC005965 | 0.329 | D0G7KJ | 0.250 | ||||
ENC001949 | 0.321 | D08BDT | 0.250 | ||||
ENC004115 | 0.319 | D01ZOG | 0.243 | ||||
ENC005964 | 0.312 | D0W5LS | 0.243 | ||||
ENC002152 | 0.309 | D04VIS | 0.240 | ||||
ENC002162 | 0.304 | D0X2LV | 0.239 | ||||
ENC005963 | 0.301 | D03MTN | 0.233 |